Cargando…
055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497033/ http://dx.doi.org/10.1016/j.jid.2021.08.057 |
| _version_ | 1784579868596371456 |
|---|---|
| author | Mahil, S.K. Bechman, K. Raharja, A. Domingo-Vila, C. Brown, M. Cope, A. Malim, M. Pollock, E. Seow, J. Barker, J. Norton, S. Galloway, J. Doores, K. Tree, T. Smith, C. |
| author_facet | Mahil, S.K. Bechman, K. Raharja, A. Domingo-Vila, C. Brown, M. Cope, A. Malim, M. Pollock, E. Seow, J. Barker, J. Norton, S. Galloway, J. Doores, K. Tree, T. Smith, C. |
| author_sort | Mahil, S.K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8497033 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84970332021-10-08 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study Mahil, S.K. Bechman, K. Raharja, A. Domingo-Vila, C. Brown, M. Cope, A. Malim, M. Pollock, E. Seow, J. Barker, J. Norton, S. Galloway, J. Doores, K. Tree, T. Smith, C. J Invest Dermatol Article Published by Elsevier Inc. 2021-10 2021-10-07 /pmc/articles/PMC8497033/ http://dx.doi.org/10.1016/j.jid.2021.08.057 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Mahil, S.K. Bechman, K. Raharja, A. Domingo-Vila, C. Brown, M. Cope, A. Malim, M. Pollock, E. Seow, J. Barker, J. Norton, S. Galloway, J. Doores, K. Tree, T. Smith, C. 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study |
| title | 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study |
| title_full | 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study |
| title_fullStr | 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study |
| title_full_unstemmed | 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study |
| title_short | 055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study |
| title_sort | 055 the impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to covid-19 vaccine bnt162b2: a cohort study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497033/ http://dx.doi.org/10.1016/j.jid.2021.08.057 |
| work_keys_str_mv | AT mahilsk 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT bechmank 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT raharjaa 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT domingovilac 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT brownm 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT copea 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT malimm 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT pollocke 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT seowj 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT barkerj 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT nortons 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT gallowayj 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT dooresk 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT treet 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy AT smithc 055theimpactofmethotrexateandtargetedimmunosuppressiononcellularandhumoralimmuneresponsestocovid19vaccinebnt162b2acohortstudy |